What are the most common inefficiencies in pharmaceutical production workflows, and what strategies have proven effective in addressing them?
How can companies optimize production processes when scaling up from small-batch to large-scale manufacturing while maintaining consistency and compliance?
What are the advantages and challenges of batch versus continuous manufacturing, and how can companies determine the best approach for their operations?
How can real-time monitoring, predictive analytics, and digital twins be used to optimize production processes and reduce deviations?
What are the biggest hurdles in applying Lean principles to pharmaceutical manufacturing, and how can they be overcome without compromising regulatory compliance?